GL1X · GenesisL1 explorer

Research workbench

HIV-1 integrase catalytic core domain (ccd) in complex with a fragment-derived allosteric inhibitor

Analyse HIV-1 integrase catalytic core domain (ccd) in complex with a fragment-derived… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5KRT
Type
protein
Length
145 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Integrase
UniProt
Q76353
Ligands
6W6
Pockets
1 · best druggability 0.28

Structure

x-ray diffraction · 1 distinct chain · 50% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AIntegraseprotein14550% helix, 19% strandQ76353

Ligands and binding sites

  • 6W6 · 3-[2,5-bis(chloranyl)pyrrol-1-yl]thiophene-2-carboxylic acid · ligand · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1550.280.7512empty

Modifications

Observed in the structure: 2 modified (nonstandard).

Compared structures

  • 5KRT · HIV-1 Integrase Catalytic Core Domain (CCD) in Complex with a Fragment-Derived Allosteric… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.